Literature DB >> 23187961

A retrospective analysis of drug-related problems documented in a national database.

Tommy Westerlund1, Ulrika Gelin, Elisabeth Pettersson, Fredrik Skärlund, Kajsa Wågström, Carina Ringbom.   

Abstract

BACKGROUND: Numerous patients are subject to drug-related problems (DRPs) every day, resulting in sub-optimal therapy, suffering and decreased quality of life, as well as in high societal health care costs. Classifying DRPs is important for the development of counselling skills and for pharmaceutical care practice and research, including assessments of the value of pharmacists' clinical interventions. Pharmacy practitioners have also reported to become more attentive to patients' drug-related needs, when requested to document their clinical interventions. Several studies have been conducted on DRPs, but there is still a need for a more thorough knowledge about their nature and the reasons for their occurrence. To examine DRP characteristics and causes by retrospectively analysing data and patient case histories, as documented by pharmacy practitioners in the Swedish national DRP database.
SETTING: Community pharmacy based patient documentation, entered into the Swedish national DRP database.
METHOD: Documented DRPs, clinical interventions and patient data were retrospectively examined and analysed. Particular attention was paid to case history reports in free text fields. Only reports containing adequate information for analysis and actual, correctly categorised DRPs were included. MAIN OUTCOME MEASURE: Subdivided DRP characteristics and causes.
RESULTS: Both similarities and differences between DRP subclasses of prescription patients (n = 5,571) and OTC drug consumers (n = 2,894) were observed. Most DRP categories could be subdivided into at least three subclasses, according to their characteristics. Causes of DRPs could be extracted from free text field reports in four prescription DRP categories and three OTC DRP categories. Uncertainty about the aim of the drug was commonly characterised by a lack of knowledge about the indication in prescription patients and in an inappropriate drug selection in OTC drug consumers. A switch from a brand-name drug to a generic drug or from one generic to another was the cause in half of the therapy failures, which in turn was a frequent reason for overuse of drug.
CONCLUSION: The study demonstrates the multi-facetted drug-related problems in patients and confirms the importance of attention by pharmacy practitioners for the detection of and intervention for DRPs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23187961     DOI: 10.1007/s11096-012-9724-1

Source DB:  PubMed          Journal:  Int J Clin Pharm


  23 in total

1.  Economic impact of increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a professional allowance.

Authors:  S I Benrimoj; J H Langford; G Berry; D Collins; R Lauchlan; K Stewart; M Aristides; M Dobson
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

2.  Preventable drug-related hospital admissions.

Authors:  Almut G Winterstein; Brian C Sauer; Charles D Hepler; Charles Poole
Journal:  Ann Pharmacother       Date:  2002 Jul-Aug       Impact factor: 3.154

3.  Pharmacy practitioners' views on computerized documentation of drug-related problems.

Authors:  L O Tommy Westerlund; Wolfgang H A Handl; Bertil R G Marklund; Peter Allebeck
Journal:  Ann Pharmacother       Date:  2003-03       Impact factor: 3.154

Review 4.  Drug-related problem classification systems.

Authors:  J W Foppe van Mil; L O Tommy Westerlund; Kurt E Hersberger; Marion A Schaefer
Journal:  Ann Pharmacother       Date:  2004-03-30       Impact factor: 3.154

5.  [Drug-related problems common in the emergency department of internal medicine. The cause of admission in almost every third patient according to quality follow-up].

Authors:  Jessica Fryckstedt; Charlotte Asker-Hagelberg
Journal:  Lakartidningen       Date:  2008 Mar 18-Apr 1

6.  Practical evaluation of the drug-related problem management process in Swiss community pharmacies.

Authors:  Jean-Marc Krähenbühl; Bertha Kremer; Bertrand Guignard; Olivier Bugnon
Journal:  Pharm World Sci       Date:  2008-04-06

7.  Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.

Authors:  Mackenzie Williams; Gregory M Peterson; Peter C Tenni; Ivan K Bindoff; Colin Curtain; Josephine Hughes; Luke Re Bereznicki; Shane L Jackson; David Cm Kong; Jeff D Hughes
Journal:  Ann Pharmacother       Date:  2011-08-30       Impact factor: 3.154

8.  Generic and therapeutic substitutions in the UK: are they a good thing?

Authors:  Martin G Duerden; Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

Review 9.  The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience.

Authors:  Linda M Strand; Robert J Cipolle; Peter C Morley; Michael J Frakes
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 10.  Brand and generic medications: are they interchangeable?

Authors:  Abdulrazaq S Al-Jazairi; Sakra Bhareth; Iyad S Eqtefan; Saleh A Al-Suwayeh
Journal:  Ann Saudi Med       Date:  2008 Jan-Feb       Impact factor: 1.526

View more
  9 in total

Review 1.  Application of drug-related problem (DRP) classification systems: a review of the literature.

Authors:  Benjamin J Basger; Rebekah J Moles; Timothy F Chen
Journal:  Eur J Clin Pharmacol       Date:  2014-05-02       Impact factor: 2.953

2.  Characterization of drug-related problems identified by clinical pharmacy staff at Danish hospitals.

Authors:  Lene Juel Kjeldsen; Trine Birkholm; Hanne Fischer; Trine Graabæk; Karina Porsborg Kibsdal; Lene Vestergaard Ravn-Nielsen; Tania Holtum Truelshøj
Journal:  Int J Clin Pharm       Date:  2014-04-16

3.  Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.

Authors:  S Desmaele; I De Wulf; A G Dupont; S Steurbaut
Journal:  Int J Clin Pharm       Date:  2015-03-31

4.  Development and validation of the Slovenian drug-related problem classification system based on the PCNE classification V 6.2.

Authors:  Nejc Horvat; Mitja Kos
Journal:  Int J Clin Pharm       Date:  2016-06-02

5.  Potential drug related problems detected by electronic expert support system in patients with multi-dose drug dispensing.

Authors:  Hammar Tora; Hovstadius Bo; Lidström Bodil; Petersson Göran; Eiermann Birgit
Journal:  Int J Clin Pharm       Date:  2014-06-29

6.  The understanding of core pharmacological concepts among health care students in their final semester.

Authors:  Patrik Aronsson; Shirley Booth; Staffan Hägg; Karin Kjellgren; Ann Zetterqvist; Gunnar Tobin; Margareta Reis
Journal:  BMC Med Educ       Date:  2015-12-29       Impact factor: 2.463

7.  Consumer views on safety of over-the-counter drugs, preferred retailers and information sources in Sweden: after re-regulation of the pharmacy market.

Authors:  Tommy Westerlund; Sahra Barzi; Cecilia Bernsten
Journal:  Pharm Pract (Granada)       Date:  2017-03-15

8.  Drug-related problems and pharmacy interventions in non-prescription medication, with a focus on high-risk over-the-counter medications.

Authors:  Hanna Ylä-Rautio; Sanna Siissalo; Saija Leikola
Journal:  Int J Clin Pharm       Date:  2020-02-20

9.  Incidence, types and acceptability of pharmaceutical interventions about drug related problems in a general hospital: an open prospective cohort.

Authors:  Valdjane Saldanha; Rand Randall Martins; Sara Iasmin Vieira Cunha Lima; Ivonete Batista de Araujo; Antonio Gouveia Oliveira
Journal:  BMJ Open       Date:  2020-04-23       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.